Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Sanofi and Regeneron's Dupixent scores in Europe as the first biologic to treat COPD
Fierce Pharma
Wed, 07/3/24 - 11:26 am
Tags:
Sanofi, Regeneron, Europe, COPD, Dupixent
Dupixent repeats as top pharma ad brand, rankings largely unchanged in May
Medical Marketing and Media
Tue, 06/11/24 - 10:49 pm
Tags:
pharma advertising, DTC advertising, Dupixent, Regeneron, Sanofi
Companies to watch for potential M&As in 2024
BioSpace
Wed, 06/5/24 - 11:31 am
Tags:
M&A, Vertex Pharmaceuticals, Regeneron, Biogen, Moderna Therapeutics
Dupixent nears EU approval for COPD, as FDA delays
Pharmaphorum
Fri, 05/31/24 - 10:49 am
Tags:
Sanofi, Regeneron, Dupixent, COPD, EMA, Europe, FDA
Who Will the Next “Big Pharma” Players Be?
BioSpace
Wed, 05/29/24 - 11:21 am
Tags:
Big Pharma, Vertex Pharmaceuticals, Regeneron, Moderna Therapeutics, Zoetis, BioNTech
ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study
BioSpace
Fri, 05/24/24 - 11:35 am
Tags:
ASCO 2024, Regeneron, clinical trials, bispecific antibodies, REGN7075, solid tumors
Despite midstage trial miss, Amgen and AstraZeneca see promise for Tezspire in COPD
Fierce Pharma
Mon, 05/20/24 - 11:25 am
Tags:
Amgen, AstraZeneca, COPD, Sanofi, Regeneron, Tezspire, Dupixent
FDA approves two biosimilars to blockbuster eye drug Eylea
Reuters
Mon, 05/20/24 - 11:23 am
Tags:
Regeneron, Eylea, FDA, biosimilars, Biocon Biologics, Yesafli, Opuviz, Samsung BioLogics, Biogen
Dupixent recaptures top Rx, OTC pharma brand spot in April
Medical Marketing and Media
Wed, 05/8/24 - 11:03 pm
Tags:
DTC advertising, Dupixent, Sanofi, Regeneron
ASGCT24: Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids
BioSpace
Wed, 05/8/24 - 11:33 am
Tags:
Regeneron, DB-OTO, genetic deafness, gene therapy, ASGCT
Regeneron, Lilly grapple with clinical endpoints as obesity space moves to improving weight loss
Fierce Biotech
Thu, 05/2/24 - 10:14 pm
Tags:
Regeneron, Eli Lilly, Zepbound, obesity, trevogrumab, bimagrumab
Regeneron Misses Q1 Earnings on Lower-Than-Expected Eylea Sales
BioSpace
Thu, 05/2/24 - 10:10 pm
Tags:
Regeneron, Eylea, earnings
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact
Reuters
Thu, 05/2/24 - 11:26 am
Tags:
Regeneron, earnings, Eylea
Dupixent’s DU More campaign breathes life into asthma treatment space
Medical Marketing and Media
Mon, 04/29/24 - 09:53 am
Tags:
Dupixent, DTC advertising, Sanofi, Regeneron
AbbVie's Rinvoq conquers Regeneron and Sanofi's Dupixent in eczema trial—again
Fierce Pharma
Fri, 04/26/24 - 11:18 am
Tags:
AbbVie, Rinvoq, Regeneron, Sanofi, Dupixent, atopic dermatitis
Regeneron expands in gene editing with Mammoth deal
BioPharma Dive
Thu, 04/25/24 - 11:31 am
Tags:
Regeneron, Mammoth Biosciences, CRISPR, gene editing
Regeneron to defend against DOJ complaint on drug-price manipulation
Yahoo/Reuters
Tue, 04/16/24 - 10:02 pm
Tags:
Regeneron, DOJ, drug pricing, Eylea
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
Fierce Biotech
Mon, 04/15/24 - 11:04 am
Tags:
Regeneron, funding, venture capital, biotech
DOJ Sues Regeneron for Allegedly Inflating Medicare Pricing for Eye Drug Eylea
BioSpace
Thu, 04/11/24 - 11:27 am
Tags:
DOJ, Regeneron, Medicare, Eylea, drug pricing, False Claims Act
COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024
BioSpace
Wed, 03/27/24 - 11:06 am
Tags:
COPD, Sanofi, Regeneron, Verona Pharma, Dupixent, ensifentrine

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.